97P Toxicity of bispecific antibody glofitamab in patients with aggressive B-cell non-Hodgkin lymphoma in real clinical practice. (December 2022) - Fedorova, L.; Smykova, O.; Chekalov, A.; Lepik, E.; Markelov, V.; Popova, M.; Kondakova, E.; Moiseev, I.; Lepik, K.; Mikhailova, N.; Kulagin, A.